Stay updated on Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.

Latest updates to the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not recruiting. New help and navigation items have been added ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'); the 'Intervention/Treatment' label was updated and a revision note 'Revision: v3.6.0' was added.SummaryDifference0.3%

- Check16 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, indicating a new iteration of the document. The change represents an update to the page’s metadata rather than substantive content changes.SummaryDifference0.0%

- Check38 days agoChange DetectedThe Revision field was updated from v3.5.3 to v3.5.4, indicating a newer document version. This update appears to be an administrative version change rather than a modification to study content or procedures.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3, reflecting an incremental website build change rather than an update to the underlying study record details.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check110 days agoChange DetectedThe page footer now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.